Skip to main content
. Author manuscript; available in PMC: 2022 Apr 26.
Published in final edited form as: Clin Infect Dis. 2021 Apr 26;72(8):1314–1322. doi: 10.1093/cid/ciaa212

Table 2.

Patient Outcomes of Patients With Pneumonia With Negative Cultures Comparing Odds of Events for Those Who Were De-escalated With Those Who Were Not De-escalated on Hospital Day 4

Outcome Unadjusted OR (95% CI) IPTW OR (95% CI) P Value

In-hospital 14-day mortality .45 (.30–.67) .65 (.39–1.08) .095
Late ICU (day 5+)a .30 (.16–.56) .38 (.18–.79) .01
Late IMV (day 5+)a .19 (.08–.45) .25 (.09–.66) .005
Late vasopressor (day 5+)a .10 (.03–.32) .13 (.04–.44) .001
CDIb .96 (.42–2.23) 1.33 (.40–4.47) .64
Costc .65 (.62–.68) .74 (.72–.76) <.001
Length of stay .70 (.68–.73) .76 (.75–.78) <.001

Data are presented as ORs (95% CIs) except for cost and length of stay (mean multipliers). Abbreviations: CDI, Clostridioides difficile infection; CI, confidence interval; ICU, intensive care unit; IMV, invasive mechanical ventilation; IPTW, Inverse Probability of Treatment Weighting; OR, odds ratio.

a

Among patients not previously in the ICU, on IMV, or on vasopressor, respectively.

b

Patients with Clostridium difficile diagnosis codes present on admission (008.45) or with a positive Clostridium difficile test by hospital day 4 were excluded.

c

Patients with no costs or from hospitals where most patients show no costs are excluded from this analysis.